|
|
Art Advanced Research Technologies Incorporated - Comparative Business Analysis Snapshot
Business Description
Art Advanced Research Technologies Incorporated. The Group's principal activities are to design, develop and market optical molecular imaging products for the healthcare and pharmaceutical industries. It has developed two products based on its innovative technology. The Group operates two segments: Pharmaceutical and Medical. The first is explore OptixTM, a molecular imaging device designed for monitoring physiological changes in living systems at the preclinical study phases of new drugs. The second is SoftScan(R), a medical imaging device designed to improve the diagnosis and treatment of breast cancer. The Group commercializes its products in a global strategic alliance with GE Healthcare.
Competitor Analysis
This analysis compares Art Advanced Research Technologies Incorporated with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
